Adjuvant Capital Investor
Adjuvant Capital is a life sciences investment firm focused on global health.
Technology:
COVID-19 Investors
Industry:
Longevity Industry 2022
Headquarters:
New York, New York, United States
Founded Date:
2012-01-01
Employees Number:
1-10
Funding Status:
N/A
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture, Late Stage Venture, Venture
Number Of Exits:
3
Total Funding:
N/A
Estimated Revenue:
$1M to $10M
Register and Claim Ownership